Skip to main content

Table 1 Clinical characteristics of S. agalactiae invasive infections in non-pregnant adults 2004 – 2012

From: Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiaein a Latin American hospital: a 17-year study

 

Total Invasive infections n = 57 n (%)

Female n = 21 n (%)

Male n = 36 n (%)

Bloodstream Infections n = 34 n (%)

Female

21 (36.8)

  

12 (35.3)

Male

36 (63.2)

  

22 (64.7)

≥60 y.o

25 (43.9)

8 (38)

15 (42)

18 (53)

Mean

 

53 y. o.

55 y. o.

 

Range

 

[17–82]

[24–83]

 

In-hospital fatality

10 (17.5)

3 (14.3)

6 (16.7)

7 (20.6)

Polymicrobial infections

13 (22.8)

2 (9.5)

11 (31)

7 (20.6)

Bloodstream infections

34 (59.7)

12 (57.1)

22 (61.1)

 

Underlying conditions

    

Cancer

14 (24.6)

8 (38)

6 (16.7)

10 (29.4)

-Hematologic malignancies

7 (12.3)

4 (19)

3 (8.3)

5 (14.7)

Diabetes

16 (28)

6 (28.6)

10 (27.8)

7 (20.6)

Transplant

4 (7)

-

2 (5.6)

1 (2.9)

Cirrhosis/liver disorder

4 (7)

1 (4.8)

3 (8.3)

3 (8.8)

Renal disorder

7 (12.3)

1 (4.8)

2 (5.6)

3 (8.8)

Lung disease

3 (5.3)

2 (9.5)

2 (5.6)

2 (5.9)

HIV

3 (5.3)

-

3 (8.3)

1 (2.9)

Autoimmune disorder

3 (5.3)

1 (4.8)

1 (2.8)

3 (8.8)

Other

3 (5.3)

2 (9.5)

2 (5.6)*

2 (5.9)**

More than one underlying condition

20 (35)

6 (28.6)

14 (38.9)

13 (38.2)

Portal of entry

    

Primary bacteremia

   

14 (41.2)

Skin and soft tissue

   

8 (23.5)

Respiratory tract

   

7 (20.6)

Gastrointestinal tract

   

4 (11.8)

Urinary tract

   

1 (2.9)

  1. y.o: years old.
  2. *No underlying condition was identified in 5 cases.
  3. **No underlying condition was identified in 2 bloodstream infections.